GC Pharma, a South Korean biopharmaceutical company, has established Curevo Inc., a Seattle-based company to support GC Pharma’s vaccine development activities. GC Pharma partnered with global health organizations IDRI (Infectious Disease Research Institute) and MIBR (Mogam Institute for Biomedical Research) to form the new company. Curevo will bring together GC Pharma’s commercial scale vaccine development and understanding of protein science with IDRI and MIBR’s scientific...